Q2 2019 Jazz Pharmaceuticals PLC Earnings Call Transcript
Welcome to the Jazz Pharmaceuticals plc Second Quarter 2019 Earnings Conference Call. (Operator Instructions)
I will now turn the call over to Kathee Littrell, Head of Investor Relations at Jazz Pharmaceuticals.
Thank you, Valerie, and thanks to those of you who are joining our investor call today. We reported our second quarter 2019 financial results and updated our financial guidance for 2019. The press release and the slide presentation accompanying this call are available on the Investors section of our website.
On the call today are Bruce Cozadd, CEO; Rob Iannone, Executive Vice President, R&D; Matt Young , EVP and CFO. And joining for the Q&A session, Dan Swisher, President and COO; Mike Miller, Executive Vice President, U.S. Commercial; Allen Yang, Senior Vice President, Clinical Development and Acting CMO.
I'd like to remind you that some of the statements we will make on this call relate to future events and performance rather than historical facts and are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |